A retrospective, cohort, real-world study of persistence of erenumab for preventive treatment of chronic and episodic migraine
Latest Information Update: 30 Nov 2021
At a glance
- Drugs Erenumab (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 30 Nov 2021 New trial record
- 22 Nov 2021 Results published in the Headache